Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...
Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback